What are the appropriate doses of Lantus (glargine) and Actrapid (human insulin) for a patient with hyperglycemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Insulin Dosing for Blood Glucose of 174 mg/dL

For a blood glucose of 174 mg/dL (9.7 mmol/L), do not give correction doses of Actrapid (regular insulin) unless this is a pre-meal reading and the patient is already on a basal-bolus regimen; instead, focus on optimizing the Lantus (glargine) dose if this represents fasting or pre-meal hyperglycemia, or initiate insulin therapy if the patient is insulin-naive. 1, 2

Context-Dependent Dosing Approach

If This is a Fasting Blood Glucose Reading

  • For insulin-naive patients: Start Lantus at 10 units once daily OR 0.1-0.2 units/kg body weight, administered at the same time each day 1, 2, 3
  • For patients already on Lantus: Increase the current dose by 2 units every 3 days until fasting glucose reaches 90-150 mg/dL (5.0-8.3 mmol/L) 1, 2
  • Target fasting glucose: Aim for <100 mg/dL (<5.5 mmol/L) to achieve HbA1c <7% 4

If This is a Pre-Meal Blood Glucose Reading

  • For patients on basal insulin only: Give correction dose of Actrapid 2-4 units before the meal, as this represents mild hyperglycemia (174 mg/dL = 9.7 mmol/L, which is <200 mg/dL) 1, 2
  • For patients not yet on prandial insulin: Consider adding Actrapid 4 units before the largest meal (representing 10% of basal dose if on ~40 units Lantus) 1, 5

If This is a Random Blood Glucose Reading

  • Assess the pattern: A single random glucose of 174 mg/dL suggests mild-to-moderate hyperglycemia requiring optimization of basal insulin rather than immediate correction 1
  • Do not rely on sliding scale alone: Correction doses without adequate basal insulin are ineffective for long-term control 1, 5

Lantus (Glargine) Dosing Principles

Administer Lantus subcutaneously once daily at the same time each day (can be morning, evening, or bedtime based on patient preference), rotating injection sites within the same region 3

Initial Dosing for Different Clinical Scenarios

  • Type 2 diabetes, insulin-naive: 0.2 units/kg OR up to 10 units once daily 3
  • Type 1 diabetes: Approximately one-third of total daily insulin requirements, with short-acting insulin covering the remainder 3
  • Severe hyperglycemia (>300 mg/dL): Start at 0.3 units/kg per day 1
  • Elderly or renal impairment: Start at lower end of dosing range (0.1 units/kg) 1

Titration Algorithm

  • If fasting glucose >150 mg/dL: Increase Lantus by 2-4 units every 3 days 1, 2
  • If fasting glucose 100-150 mg/dL: Increase by 2 units every 3 days 2
  • If fasting glucose <80 mg/dL on two occasions per week: Decrease by 2 units 2
  • More aggressive titration: Patient-managed increases of 2 units every 3 days (in absence of hypoglycemia) achieve better HbA1c reduction than clinic-managed titration 4

Actrapid (Regular Human Insulin) Dosing

Actrapid should be given 30 minutes before meals (unlike rapid-acting analogs which are given immediately before eating), making it less convenient than modern rapid-acting insulins 1

When to Add Prandial Insulin

  • Basal insulin optimized but A1C still elevated: Add Actrapid 4 units before the largest meal 1, 5
  • Severe hyperglycemia (>300 mg/dL): Initiate basal-bolus regimen with 50% of total daily dose as basal (Lantus) and 50% as prandial (Actrapid divided before meals) 1
  • Pre-meal glucose consistently >180 mg/dL: Add prandial coverage 1

Correction Dose Calculation

  • For pre-meal glucose 150-200 mg/dL: Give 2 units Actrapid 1
  • For pre-meal glucose 200-250 mg/dL: Give 4 units Actrapid 1
  • Adjust based on insulin sensitivity: These are starting points requiring individualization 1

Critical Warnings and Pitfalls

Do Not Mix Insulins

Never mix Lantus with Actrapid or any other insulin in the same syringe, as Lantus will coprecipitate other insulins and alter their pharmacokinetics 3, 6

Timing Considerations

  • Lantus: Once daily at consistent time, can be any time of day 3, 6
  • Actrapid: 30 minutes before meals (unlike rapid-acting analogs) 1
  • For steroid-induced hyperglycemia: Consider NPH in the morning rather than Lantus, as steroids cause peak hyperglycemia 7-9 hours after dosing 1, 7

Hypoglycemia Risk

  • Lantus has 26% lower risk of nocturnal hypoglycemia compared to NPH insulin, and 46% lower risk of severe hypoglycemia 8, 9
  • Monitor glucose before meals and at bedtime during dose adjustments 1, 3
  • If hypoglycemia occurs: Reduce corresponding insulin dose by 10-20% 1

Special Populations

  • Elderly patients: Start at lower doses (0.1 units/kg) due to increased hypoglycemia risk 1, 5
  • Renal impairment: Lower initial doses and slower titration 1
  • On corticosteroids: May require higher doses (consider 0.5 units/kg total daily dose) and more frequent adjustments as steroid dose changes 1, 7

Monitoring Requirements

  • Increase frequency of glucose monitoring during any insulin regimen changes 3
  • Check fasting glucose daily when titrating basal insulin 2
  • Reassess every 2-3 months with HbA1c monitoring 5
  • Evaluate for overbasalization: If bedtime-to-morning glucose differential is high or postprandial excursions are excessive despite optimized basal insulin, add prandial coverage rather than increasing basal further 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.